1
|
Development of on-line high performance liquid chromatography (HPLC)-biochemical detection methods as tools in the identification of bioactives. Int J Mol Sci 2012; 13:3101-3133. [PMID: 22489144 PMCID: PMC3317705 DOI: 10.3390/ijms13033101] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2011] [Revised: 02/08/2012] [Accepted: 03/01/2012] [Indexed: 11/23/2022] Open
Abstract
Biochemical detection (BCD) methods are commonly used to screen plant extracts for specific biological activities in batch assays. Traditionally, bioactives in the most active extracts were identified through time-consuming bio-assay guided fractionation until single active compounds could be isolated. Not only are isolation procedures often tedious, but they could also lead to artifact formation. On-line coupling of BCD assays to high performance liquid chromatography (HPLC) is gaining ground as a high resolution screening technique to overcome problems associated with pre-isolation by measuring the effects of compounds post-column directly after separation. To date, several on-line HPLC-BCD assays, applied to whole plant extracts and mixtures, have been published. In this review the focus will fall on enzyme-based, receptor-based and antioxidant assays.
Collapse
|
2
|
Eggink M, Wijtmans M, Ekkebus R, Lingeman H, Esch IJPD, Kool J, Niessen WMA, Irth H. Development of a Selective ESI-MS Derivatization Reagent: Synthesis and Optimization for the Analysis of Aldehydes in Biological Mixtures. Anal Chem 2008; 80:9042-51. [DOI: 10.1021/ac801429w] [Citation(s) in RCA: 97] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Mark Eggink
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Maikel Wijtmans
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Reggy Ekkebus
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Henk Lingeman
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Iwan J. P. de Esch
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Jeroen Kool
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Wilfried M. A. Niessen
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| | - Hubertus Irth
- Leiden/Amsterdam Center for Drug Research, Faculty of Sciences, Department of Chemistry, Section of Analytical Chemistry & Applied Spectroscopy, and Department of Pharmacochemistry, Section of Medicinal Chemistry, VU University Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
| |
Collapse
|
4
|
van Bommel MR, de Jong AP, Tjaden UR, Irth H, van der Greef J. High-performance liquid chromatography coupled to enzyme-amplified biochemical detection for the analysis of hemoglobin after pre-column biotinylation. J Chromatogr A 2000; 886:19-29. [PMID: 10950272 DOI: 10.1016/s0021-9673(00)00481-7] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The determination of proteins with enzyme-amplified biochemical detection (EA-BCD) coupled on-line with high-performance liquid chromatography (HPLC) is demonstrated. The EA-BCD system was developed to detect biotin-containing compounds. Hemoglobin, which was used as a model compound, was biotinylated prior to sample introduction. Several biotinylation parameters, such as pH and removal of excess biotinylation reagent, were investigated. After biotinylation samples were introduced to HPLC followed by EA-BCD. To the HPLC effluent, alkaline phosphatase label streptavidin (S-AP) was added, which possesses high affinity to biotin and biotin-containing compounds. Excess S-AP was removed by means of an immobilized biotin column followed by substrate addition. The non-fluorescent substrate is converted to a highly fluorescent product by the enzyme label. A detection limit of 2 femtomol biotinylated Hb was achieved with good reproducibility and linearity. However, biotinylation at low analyte concentration suffers from low yield due to slow reaction kinetics. Finally, Hb was successfully extracted from urine with a recovery of 94%.
Collapse
Affiliation(s)
- M R van Bommel
- Division of Analytical Chemistry, Leiden/Amsterdam Center of Drug Research, Leiden University, The Netherlands
| | | | | | | | | |
Collapse
|
5
|
van Bommel MR, de Jong AP, Tjaden UR, Irth H, van der Greef J. Enzyme amplification as detection tool in continuous-flow systems. I. Development of an enzyme-amplified biochemical detection system coupled on-line to flow-injection analysis. J Chromatogr A 1999; 855:383-96. [PMID: 10519082 DOI: 10.1016/s0021-9673(99)00744-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The on-line coupling of flow-injection analysis (FIA) to an enzyme-amplified biochemical detection (EA-BCD) system is described. The aim of this study is the development of a detection system able to detect biotin-containing compounds at low concentration levels. The detection system is based on the interaction of biotin with enzyme-labeled affinity proteins. Biotin possesses a high affinity to both streptavidin and anti-biotin Fab fragments, which are both tested. Several biotin derivatives are available with different reactive probes, which can be used to label analytes of interest. Therefore, biotin acts as a universal probe for the enzyme-amplified biochemical detection. Alkaline phosphatase (AP) was used as enzyme label. Several parameters, such as substrate type and concentration, concentration of enzyme-labeled affinity protein, reaction time and reaction temperature were examined. Biotin aminocaproic acid was used as a model compound. In addition to biotin aminocaproic hydrazide, other biotinylation reagents were also examined. With fluorescence detection of the enzyme-generated product, a mass detection limit of 1 fmol was achieved.
Collapse
Affiliation(s)
- M R van Bommel
- Division of Analytical Chemistry, Leiden/Amsterdam Center of Drug Research, Leiden University, The Netherlands
| | | | | | | | | |
Collapse
|